UroGen Pharma Appoints Peter P. Pfreundschuh as Chief Financial Officer
Go back to UroGen Pharma Appoints Peter P. Pfreundschuh as Chief Financial Officer| (NASDAQ: URGN) | Delayed: 42.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.24 | 52 Week High | $ | |||
| Open | $42.24 | 52 Week Low | $ | |||
| Day High | $42.24 | P/E | N/A | |||
| Day Low | $42.24 | EPS | $ | |||
| Volume | 24 | |||||
| (NASDAQ: URGN) | Delayed: 42.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.24 | 52 Week High | $ | |||
| Open | $42.24 | 52 Week Low | $ | |||
| Day High | $42.24 | P/E | N/A | |||
| Day Low | $42.24 | EPS | $ | |||
| Volume | 24 | |||||

